This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Doreen Könning: Innovator in Antibody Research
Introduction
Doreen Könning is a prominent inventor based in Darmstadt, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies.
Latest Patents
Doreen holds a patent for "ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOF." This innovative work showcases her expertise in creating targeted therapies that can potentially improve treatment outcomes in various medical conditions.
Career Highlights
Doreen is currently employed at Merck Patent GmbH, where she continues to advance her research and development efforts. Her work at Merck has positioned her as a key player in the biotechnology sector.
Collaborations
Doreen collaborates with esteemed colleagues, including Sabine Raab-Westphal and Stefan Hecht. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Doreen Könning is a trailblazer in antibody research, with a focus on innovative solutions that can lead to significant advancements in medical treatments. Her contributions to the field are noteworthy and continue to inspire future innovations.